Abel Hall LLC’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Buy
2,865
+596
+26% +$221K 0.21% 65
2026
Q1
$614K Sell
2,269
-1,666
-42% -$496K 0.13% 141
2025
Q4
$1.3M Buy
3,935
+837
+27% +$284K 0.3% 43
2025
Q3
$1.07M Buy
3,098
+145
+5% +$43.9K 0.43% 33
2025
Q2
$921K Buy
2,953
+2,280
+339% +$871K 0.43% 36
2025
Q1
$353K Sell
673
-178
-21% -$91K 0.21% 83
2024
Q4
$431K Sell
851
-82
-9% -$46.6K 0.27% 60
2024
Q3
$546K Buy
933
+83
+10% +$46.9K 0.36% 42
2024
Q2
$433K Sell
850
-91
-10% -$44.6K 0.31% 52
2024
Q1
$465K Buy
941
+14
+2% +$7.12K 0.35% 46
2023
Q4
$488K Buy
+927
New +$494K 0.42% 40

Other funds holding UNH

Abel Hall LLC's UNH Position: Q2 2026 in Review

Abel Hall LLC increased its UnitedHealth (UNH) stake by 26% in Q2 2026, buying an estimated $221K and bringing the position to 2,865 shares worth $1.19M. The position accounts for 0.21% of the portfolio, ranked #65.

Abel Hall LLC first reported a position in UNH in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.3M in Q4 2025. 1,266 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Abel Hall LLC held 2,865 shares of UnitedHealth worth $1.19M as of Q2 2026.
  • Abel Hall LLC bought 596 UnitedHealth shares in Q2 2026, an estimated $221K.
  • UnitedHealth made up 0.21% of Abel Hall LLC's portfolio in Q2 2026, its #65 holding.
  • Abel Hall LLC first reported a position in UnitedHealth in Q4 2023 and has held it in 11 quarters since.
  • Abel Hall LLC's UnitedHealth position peaked at $1.3M in Q4 2025.
  • 1,266 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.